Reply to letter to the editor: Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder by Pitarokoili and Gold

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)366-367
Number of pages2
JournalMultiple Sclerosis Journal
Volume24
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Neuromyelitis Optica
Gold
Dimethyl Fumarate

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

@article{5cc77a267f664936b579db865452692d,
title = "Reply to letter to the editor: Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder by Pitarokoili and Gold",
author = "Kira, {Jun Ichi}",
year = "2018",
month = "3",
day = "1",
doi = "10.1177/1352458517721978",
language = "English",
volume = "24",
pages = "366--367",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Reply to letter to the editor

T2 - Dimethyl fumarate for patients with neuromyelitis optica spectrum disorder by Pitarokoili and Gold

AU - Kira, Jun Ichi

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85042861809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042861809&partnerID=8YFLogxK

U2 - 10.1177/1352458517721978

DO - 10.1177/1352458517721978

M3 - Letter

AN - SCOPUS:85042861809

VL - 24

SP - 366

EP - 367

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 3

ER -